Glass House Brands (GLAS) Net Cash Flow (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Net Cash Flow of $4.6 million for Q1 2026, up 561.42% year-over-year from $692000.0 in Q1 2025, and up 170.76% quarter-over-quarter from -$6.5 million in Q4 2025.
Glass House Brands (GLAS) Net Cash Flow (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Net Cash Flow for 7 consecutive years, with $4.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow rose 561.42% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at -$9.7 million (down 173.71% YoY), while the FY2025 annual figure was -$13.6 million, down 409.62% from the prior year.
- Net Cash Flow advanced to $4.6 million in Q1 2026 per GLAS's latest filing, from -$6.5 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $23749.3 billion in Q3 2023 and bottomed at -$29234.1 billion in Q4 2022.
- Historically, Net Cash Flow has averaged -$322.6 billion across 5 years, with a median of $6.6 million in 2025.
- Annual changes were most pronounced in 2023 — Net Cash Flow surged 152392558.92% — and 2025, when it tumbled 447.18%.
- Glass House Brands' Net Cash Flow stood at -$29234.1 billion in 2022, then surged by 100.0% to $8.2 million in 2023, then tumbled by 77.42% to $1.9 million in 2024, then sank by 447.18% to -$6.5 million in 2025, then soared by 170.76% to $4.6 million in 2026.
- Business Quant data shows GLAS's Net Cash Flow at $4.6 million in Q1 2026, -$6.5 million in Q4 2025, and -$14.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.47 Bn | 43.51 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.56 Bn | 39.90 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.32 Bn | 30.65 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.07 Bn | 19.41 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.96 Bn | 18.07 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.46 Bn | 15.07 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Glass House Brands | 865.83 Mn | 847.27 Mn | 15.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.58 Mn |
| Mar 31, 2026 | 4.58 Mn |
| Dec 31, 2025 | -6.47 Mn |
| Dec 31, 2025 | -6.47 Mn |
| Sep 30, 2025 | -14.43 Mn |
| Sep 30, 2025 | -14.43 Mn |
| Jun 30, 2025 | 6.59 Mn |
| Jun 30, 2025 | 6.59 Mn |
| Mar 31, 2025 | 692,000.00 |
| Mar 31, 2025 | 692,000.00 |
| Dec 31, 2024 | 1.86 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 9.18 Mn |
| Sep 30, 2024 | 9.18 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | -8.12 Mn |
| Mar 31, 2024 | -8.12 Mn |
| Dec 31, 2023 | 8.25 Mn |
| Dec 31, 2023 | 8.25 Mn |